Three venture capital funds have agreed to provide $3.6 million for Altheus Therapeutics of Oklahoma City.

St Louis-based Prolog Ventures was the group leader. Prolog specializes in early-stage life science companies. Prolog was joined by Tulsa-based Oklahoma Equity Partners, which is managed by Dave Humphrey, and the Oklahoma Seed Capital Fund, which was started this year and capitalized by the Oklahoma Center for the Advancement of Science and Technology, the Oklahoma Development Finance Authority and the Oklahoma Capital Investment Board.